RORA-AS1: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

Target Name: RORA-AS1

NCBI ID: G101928784

RORA-AS1

Other Name(s): RORA-AS1 variant 3 | RORA antisense RNA 1 | RORA-AS1 variant 1

RORA-AS1: A Non-Coding RNA Molecule with Potential as a Drug Target and Biomarker

RORA-AS1 (RORA-AS1 variant 3) is a gene that encodes a protein known as RORA-AS1. RORA-AS1 is a non-coding RNA molecule that has been shown to play a role in various cellular processes, including cell signaling, gene regulation, and intracellular signaling. Despite its importance, little is known about RORA-AS1 specifically.

In this article, we will explore RORA-AS1, its function, potential drug targets, and its potential as a biomarker.

Function and Putative Functions

RORA-AS1 is a non-coding RNA molecule that contains 21 amino acid residues. It is located in the X chromosome and has been shown to play a role in various cellular processes. One of its well-known functions is that it regulates cell signaling by activating the negative signaling pathway of the NF-kappa pathway.

In addition to its role in cell signaling, RORA-AS1 has also been shown to play a role in gene regulation. It has been shown to act as a negative regulator of the gene encoding the protein, known as NF-kappa2. This suggests that RORA-AS1 may be a potential drug target for the treatment of NF-kappa-related diseases.

Potential Drug Targets

RORA-AS1 has been shown to be a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. One of the reasons for its potential as a drug target is its unique structure, which allows it to interact with various signaling pathways.

For example, RORA-AS1 has been shown to interact with the protein known as SIRT1, which is a natural antioxidant that has been shown to have various health benefits. SIRT1 has also been shown to interact with RORA-AS1, suggesting that RORA-AS1 may be a potential drug target for diseases that are characterized by oxidative stress.

Another potential drug target for RORA-AS1 is its role in intracellular signaling. It has been shown to play a role in the regulation of various cellular processes, including cell signaling, DNA replication, and apoptosis. This suggests that RORA-AS1 may be a potential drug target for diseases that are characterized by abnormal cellular signaling.

Potential as a Biomarker

In addition to its potential as a drug target, RORA-AS1 has also been shown to have potential as a biomarker. Its unique structure and various functions make it an attractive candidate for use as a biomarker for various diseases.

For example, RORA-AS1 has been shown to have potential as a biomarker for cancer. Its regulation of the NF-kappa pathway has been shown to play a role in the development and progression of various types of cancer. Therefore, RORA-AS1 may be a potential biomarker for cancer diagnosis and treatment.

Another potential application for RORA-AS1 as a biomarker is its role in neurodegenerative diseases. Its regulation of the NF-kappa pathway has been shown to play a role in the development and progression of neurodegenerative diseases. Therefore, RORA-AS1 may be a potential biomarker for neurodegenerative diseases.

Conclusion

In conclusion, RORA-AS1 is a gene that encodes a protein with various functions, including cell signaling, gene regulation, and intracellular signaling. Its unique structure and potential as a drug target and biomarker make it an attractive candidate for further research. Further studies are needed to fully understand its functions and potential applications in medicine.

Protein Name: RORA Antisense RNA 1

The "RORA-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RORA-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets